Product
Rabies vaccine
4 clinical trials
2 indications
Indication
RabiesIndication
MalariaClinical trial
A Phase 2b Randomized Blinded Study to Evaluate SYN023 Compared to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies in Adults With Different Rabies Exposure RisksStatus: Completed, Estimated PCD: 2021-12-23
Clinical trial
Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or With-out Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of AgeStatus: Completed, Estimated PCD: 2019-11-04
Clinical trial
A Phase IIb Randomised Controlled Trial of the Safety, Immunogenicity and Efficacy of the Blood-stage Malaria Vaccine Candidates RH5.1 in Matrix-MTM and RH5.2-VLP in Matrix-MTM in Infants Aged 5-17 Months in Burkina Faso.Status: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
A Phase III Randomized Controlled Multi-centre Trial to Evaluate the Efficacy of the R21/Matrix-M Vaccine in African Children Against Clinical MalariaStatus: Active (not recruiting), Estimated PCD: 2023-03-21